Prismlab
Develops industrial-grade SLA 3D printing systems using proprietary Subpixel Micro Scan (SMS) technology for mass continuous production.
- CEO / Founder
- Hou Feng
- Team Size
- 51-200
- Stage
- Active
- Total Funding
- $29M
- Latest Round
- Series C
- Key Investors
- Qiming Venture Partners (Series C lead), BASF Venture Capital (Series A), Jinyu Bogor (Series C), Duowei Capital (financial advisor)
Technology & Products
Key Products
Industrial-grade SLA 3D printing systems, consumables, and overall 3D printing solution services. Focuses on high-precision applications including medical (invisible orthodontics) and microfluidics.
Technological Advantage
SMS technology enables high-speed mass production with high precision, bridging the gap between prototyping and industrial manufacturing.
Differentiation
Value Proposition
Enables mass continuous production by combining high exposure area with sub-pixel accuracy, significantly increasing throughput for industrial and medical applications.
How They Differentiate
Proprietary SMS technology allows for high-speed continuous production at a scale and precision that traditional SLA systems struggle to match.
Market & Competition
Target Customers
Medical device and dental manufacturers requiring high-precision mass production.
Industry Verticals
Medical; Dental; Industrial Manufacturing
Competitors
UnionTech; HeyGears; Carbon
Growth & Milestones
Growth Metrics
Estimated annual revenue of $5.4M; global distribution network spanning 50 countries; R&D-heavy workforce (50% of staff).
Major Milestones
Founded in 2005; Strategic partnership with BASF; Raised 200 million yuan in Series C funding
Notable Customers
BASF (Strategic Partner/Investor); dental laboratories and orthodontic clinics in 50+ countries.